COYA THERAPEUTICS INC (COYA) Stock Earnings Estimates
NASDAQ:COYA • US22407B1089
4.69 USD
-0.22 (-4.48%)
Last: Mar 3, 2026, 04:30 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.002M | 3.554M -40.79% | 6.042M 70.00% | 594.997K -90.15% | 8.84M 1,385.72% | 12.75M 44.23% | 13.26M 4.00% | 18.856M 42.20% | 118.64M 529.19% | 232.72M 96.16% | 351.1M 50.87% | ||
| EBITDA YoY % growth | -9.78M -101.65% | -7.333M 25.02% | -17.197M -134.53% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.81M -101.44% | -7.36M 24.97% | -17.225M -134.02% | -21.918M -27.25% | -31.066M -41.74% | -25.203M 18.87% | -26.024M -3.26% | -25.029M 3.82% | -21.51M 14.06% | 79.783M 470.91% | 188.82M 136.67% | 302.17M 60.03% | |
| Operating Margin | N/A | -122.63% | -484.64% | -362.75% | -5,221.23% | -285.10% | -204.11% | -188.76% | -114.07% | 67.25% | 81.14% | 86.06% | |
| EPS YoY % growth | N/A | -0.79 57.44% | -0.97 -22.78% | -1.22 -25.59% | -1.52 -24.52% | -1.19 21.55% | -0.21 82.00% | -0.34 -57.14% | 0.10 130.30% | 2.99 2,830.00% | 6.67 123.21% | 9.52 42.66% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -63.72% | -0.36 18.09% | -0.42 -15.69% | -0.44 -237.38% | -0.38 -34.87% |
| Revenue Q2Q % growth | 1.967M 100,771.79% | 214.2K -16.98% | 163.2K -0.49% | 122.4K -96.57% | 102K -94.81% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.064M -24.10% | -7.111M 7.37% | -7.934M -23.68% | -8.215M -328.58% | -8.243M -62.79% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.13 50.00% | -0.28 | 0.15 | 53.37% |
| Q2 2025 Q2Q % growth | -0.36 -89.47% | -0.40 | 0.04 | 10.16% |
| Q1 2025 Q2Q % growth | -0.44 -25.71% | -0.20 | -0.24 | -121.22% |
| Q4 2024 Q2Q % growth | -0.17 -160.71% | -0.27 | 0.10 | 37.11% |
| Q3 2024 Q2Q % growth | -0.26 45.83% | -0.42 | 0.16 | 38.58% |
| Q2 2024 Q2Q % growth | -0.19 38.71% | -0.14 | -0.05 | -33.05% |
| Q1 2024 Q2Q % growth | -0.35 -25.00% | -0.31 | -0.04 | -14.38% |
| Q4 2023 Q2Q % growth | 0.28 | 0.27 | 0.01 | 5.58% |
| Q3 2023 Q2Q % growth | -0.48 | -0.38 | -0.10 | -27.19% |
| Q2 2023 Q2Q % growth | -0.31 | -0.33 | 0.02 | 5.02% |
| Q1 2023 Q2Q % growth | -0.28 | -0.44 | 0.16 | 36.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 3.564M | 3.774M | -210K | -5.56% |
| Q2 2025 Q2Q % growth | 164K -95.21% | 798.997K | -634.997K | -79.47% |
| Q1 2025 Q2Q % growth | 258K 103.15% | 2.686M | -2.428M | -90.39% |
| Q4 2024 Q2Q % growth | 1.95K -99.97% | 68.003K | -66.053K | -97.13% |
| Q3 2024 Q2Q % growth | 178.5K | -178.5K | -100.00% | |
| Q2 2024 Q2Q % growth | 3.425M | 3.978M | -552.73K | -13.89% |
| Q4 2023 Q2Q % growth | 6.002M | 7.65M | -1.648M | -21.54% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.05% | 8.28% | 0.59% | 21.21% |
| Revenue | 0% | -3.58% | 0% | 20.74% |